DE602005003394D1 - Verfahren zur Abtrennung und Inaktivierung von Virus- und Prionenkontaminationen - Google Patents

Verfahren zur Abtrennung und Inaktivierung von Virus- und Prionenkontaminationen

Info

Publication number
DE602005003394D1
DE602005003394D1 DE602005003394T DE602005003394T DE602005003394D1 DE 602005003394 D1 DE602005003394 D1 DE 602005003394D1 DE 602005003394 T DE602005003394 T DE 602005003394T DE 602005003394 T DE602005003394 T DE 602005003394T DE 602005003394 D1 DE602005003394 D1 DE 602005003394D1
Authority
DE
Germany
Prior art keywords
inactivation
virus
separation
prion contamination
prion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005003394T
Other languages
English (en)
Other versions
DE602005003394T2 (de
Inventor
Maurizio Dattilo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IBSA Institut Biochimique SA
Original Assignee
IBSA Institut Biochimique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IBSA Institut Biochimique SA filed Critical IBSA Institut Biochimique SA
Publication of DE602005003394D1 publication Critical patent/DE602005003394D1/de
Application granted granted Critical
Publication of DE602005003394T2 publication Critical patent/DE602005003394T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088Liquid substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE602005003394T 2004-05-04 2005-05-02 Verfahren zur Abtrennung und Inaktivierung von Virus- und Prionenkontaminationen Active DE602005003394T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000891A ITMI20040891A1 (it) 2004-05-04 2004-05-04 Nuovo metodo per la partizione ed inattivazione di contaminanti virali e prionici
ITMI20040891 2004-05-04

Publications (2)

Publication Number Publication Date
DE602005003394D1 true DE602005003394D1 (de) 2008-01-03
DE602005003394T2 DE602005003394T2 (de) 2008-09-25

Family

ID=34939640

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005003394T Active DE602005003394T2 (de) 2004-05-04 2005-05-02 Verfahren zur Abtrennung und Inaktivierung von Virus- und Prionenkontaminationen

Country Status (7)

Country Link
US (1) US20050250935A1 (de)
EP (1) EP1593688B1 (de)
JP (1) JP4610409B2 (de)
CA (1) CA2506334A1 (de)
DE (1) DE602005003394T2 (de)
ES (1) ES2296077T3 (de)
IT (1) ITMI20040891A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0509148B8 (pt) 2004-03-22 2021-05-25 Abbott Products Gmbh composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina contendo tensoativos, seus usos e respectivos processos de fabricação
CN101233229B (zh) 2005-07-29 2013-05-01 雅培实验室有限公司 制备消毒的胰酶粉末的方法
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
CA2653127C (en) * 2006-05-22 2015-09-15 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
JP5473929B2 (ja) * 2007-11-15 2014-04-16 アボット ラボラトリーズ ゲゼルシャフト ミット ベシュレンクテル ハフツング パンクレアチン試料中のウイルス負荷を分離及び測定するための新規の方法
IT201600079328A1 (it) * 2016-07-28 2018-01-28 Altergon Sa Metodo migliorato per la decontaminazione di materiale biologico mediante partizione e inattivazione

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT408191B (de) * 1991-08-19 2001-09-25 Haemosan Erzeugung Pharmazeuti Verfahren zur inaktivierung von prionen
JP3017887B2 (ja) * 1992-07-24 2000-03-13 ヘモサン ゲ−エムベ−ハ エルツォイグング ファ−マツオィティシャ グルントゥシュトッファ プリオネン、ウイルス及び他の感染因子の不活化方法
US5750361A (en) * 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
DE69836758T2 (de) * 1997-11-06 2007-10-11 Innogenetics N.V. Apo b, annexin v und tubulin: medizinische und diagnostische verwendung und verwendung zur purifikation von hcv
CN100507567C (zh) * 2002-05-23 2009-07-01 奥索临床诊断有限公司 朊病毒蛋白的去除

Also Published As

Publication number Publication date
ITMI20040891A1 (it) 2004-08-04
DE602005003394T2 (de) 2008-09-25
ES2296077T3 (es) 2008-04-16
JP4610409B2 (ja) 2011-01-12
EP1593688A1 (de) 2005-11-09
CA2506334A1 (en) 2005-11-04
US20050250935A1 (en) 2005-11-10
JP2005319302A (ja) 2005-11-17
EP1593688B1 (de) 2007-11-21

Similar Documents

Publication Publication Date Title
EP1855649A4 (de) Verfahren zur behandlung von atherosklerose, hyperlipidämien und verwandten erkrankungen
EP1905443A4 (de) Flüssigkeit zur prävention von gewebeadhäsion und verfahren zur verhinderung von gewebeadhäsion
ATE500824T1 (de) Verfahren zur reinigung von trans-(-)-delta9- tetrahydrocannabinol und trans-(+)-delta9- tetrahydrocannabinol
DE602004002618D1 (de) Verfahren und System zur Kantenhervorhebung
ATE466537T1 (de) System zur spaltung und entfernung von proteinösem gewebe
DE502006007362D1 (de) System zur Erkennung und Verwaltung von Paletten
DE602004006790D1 (de) Verfahren und Gerät zur Klassifikation von Defekten
EP1945284A4 (de) Spritzenvorrichtungen, bauteile von spritzenvorrichtungen und verfahren zur ausbildung von bauteilen und spritzenvorrichtungen
ATE512636T1 (de) System und verfahren zur identifizierung und kontrolle von ophthalmischen chirurgischen vorrichtungen und komponenten
DE502006008374D1 (de) Verfahren und Vorrichtung zur Detektion und Sortierung von Glas
EP2062127A4 (de) Verfahren und system zur durchsuche von sichtbarem inhalt
DE602004015053D1 (de) Vorrichtung und Verfahren zur Realisation von VoIP services
DE602006008098D1 (de) Verfahren und System zur Verwaltung von Datenverkehr
DE602004031106D1 (de) Verfahren und vorrichtung zur verfestigung von glas
DE602005014669D1 (de) System und verfahren zur verpackung von produkten
DE602005007219D1 (de) Verfahren und Vorrichtung zur Trennung von Schallquellensignalen
DE602006004529D1 (de) Verfahren und Vorrichtung zur Kontrolle von Objekten
DE602005009060D1 (de) System und Vorrichtung zur Verwaltung von Artikeln
DE60309647D1 (de) System und Verfahren zur gesicherten Behandlung von Kontrollinformationen
EP1773388A4 (de) Sars-impfstoffe und verfahren zur herstellung von hochaktiven antikörpern
DE112004001110D2 (de) System und Verfahren zur Bearbeitung von Werteinheiten
DE602004032478D1 (de) Eidung und verfahren zur stromlosen metallabscheidung unter verwendung davon
EP1863685A4 (de) System und verfahren zur anordnung von objekten und verbindung derselben
DE602005003394D1 (de) Verfahren zur Abtrennung und Inaktivierung von Virus- und Prionenkontaminationen
ATE461919T1 (de) Verfahren zur herstellung von montelukast und zwischenprodukte dafür

Legal Events

Date Code Title Description
8364 No opposition during term of opposition